Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


27.02.2017

1 AJR Am J Roentgenol
1 Am J Clin Oncol
1 BJU Int
1 Br J Cancer
1 Cancer
1 Cancer Imaging
1 Cancer Lett
1 Cancer Res
1 Clin Cancer Res
5 Eur Urol
2 Int J Urol
1 J Cell Physiol
1 J Nucl Med
10 J Urol
1 Nat Rev Urol
1 PLoS Comput Biol
1 PLoS One
1 Urol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. ROSENKRANTZ AB, Oto A, Turkbey B, Westphalen AC, et al
    Prostate Imaging Reporting and Data System (PI-RADS), Version 2: A Critical Look.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  2. SHAIKH MP, Alite F, Wu MJ, Solanki AA, et al
    Adjuvant Radiotherapy Versus Wait-and-See Strategy for Pathologic T3 or Margin-Positive Prostate Cancer: A Meta-Analysis.
    Am J Clin Oncol. 2017 Feb 20. doi: 10.1097/COC.0000000000000358.
    PubMed     Text format     Abstract available


    BJU Int

  3. SPAHN M, Morlacco A, Boxler S, Joniau S, et al
    Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: A multi-institutional study of 62 patients.
    BJU Int. 2017 Feb 20. doi: 10.1111/bju.13818.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. LEHTO US, Tenhola H, Taari K, Aromaa A, et al
    Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.
    Br J Cancer. 2017 Feb 21. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer


  5. Erratum: Activation of nuclear factor kappaB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.
    Cancer. 2017;123:892-893.
    PubMed     Text format    


    Cancer Imaging

  6. COUNAGO F, Recio M, Maldonado A, Del Cerro E, et al
    Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.
    Cancer Imaging. 2016;16:42.
    PubMed     Text format     Abstract available


    Cancer Lett

  7. MARTINEZ DE PINILLOS BAYONA A, Woodhams JH, Pye H, Hamoudi RA, et al
    Efficacy of photochemical internalisation using disulfonated chlorin and porphyrin photosensitisers: an in vitro study in 2D and 3D prostate cancer models.
    Cancer Lett. 2017 Feb 18. pii: S0304-3835(17)30127.
    PubMed     Text format     Abstract available


    Cancer Res

  8. ZHANG K, Guo Y, Wang X, Zhao H, et al
    WNT/beta-catenin directs self-renewal symmetric cell division of hTERThigh prostate cancer stem cells.
    Cancer Res. 2017 Feb 16. pii: canres.1887.2016.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  9. RATHKOPF DE, Antonarakis ES, Shore ND, Tutrone RF, et al
    Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone.
    Clin Cancer Res. 2017 Feb 17. pii: clincanres.2509.2016.
    PubMed     Text format     Abstract available


    Eur Urol

  10. VALE S
    Re: Cesare Cozzarini. Whole-pelvis Radiotherapy in the Radiation Treatment of Intermediate- and High-risk Prostate Cancer: How to Improve the Therapeutic Ratio of a Potentially Effective but still Unsatisfactory Treatment? Eur Urol 2017;71:44-5: Precl
    Eur Urol. 2017 Feb 14. pii: S0302-2838(17)30089.
    PubMed     Text format    

  11. COZZARINI C, Benigni F, Fiorino C, Mondino A, et al
    Reply to Salvador Vale's Letter to the Editor re: Cesare Cozzarini. Whole-pelvis Radiotherapy in the Radiation Treatment of Intermediate- and High-risk Prostate Cancer: How to Improve the Therapeutic Ratio of a Potentially Effective but still Unsatisf
    Eur Urol. 2017 Feb 14. pii: S0302-2838(17)30090.
    PubMed     Text format    

  12. GANDAGLIA G, Fossati N, Montorsi F, Briganti A, et al
    Reply to Pascal Mouracade's Letter to the Editor re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Uro
    Eur Urol. 2017 Feb 14. pii: S0302-2838(17)30086.
    PubMed     Text format    

  13. PRUTHI DK, Ankerst DP, Liss MA
    Novel Definitions of Low-risk and High-risk Prostate Cancer: Implications for the European Randomized Study of Screening for Prostate Cancer Risk Assessment Tool.
    Eur Urol. 2017 Feb 17. pii: S0302-2838(17)30098.
    PubMed     Text format    

  14. DAL MORO F, Motterle G, Barbieri L, Zattoni F, et al
    Re: Jean-Pierre Droz, Gilles Albrand, Silke Gillessen, et al. Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo
    Eur Urol. 2017 Feb 15. pii: S0302-2838(17)30088.
    PubMed     Text format    


    Int J Urol

  15. SHOJI S, Hiraiwa S, Ogawa T, Kawakami M, et al
    Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naive men.
    Int J Urol. 2017 Feb 21. doi: 10.1111/iju.13306.
    PubMed     Text format     Abstract available

  16. EGEVAD L, Samaratunga H, Delahunt B
    Editorial Comment to Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam.
    Int J Urol. 2017 Feb 17. doi: 10.1111/iju.13305.
    PubMed     Text format    


    J Cell Physiol

  17. RYU S, Lim W, Bazer FW, Song G, et al
    Chrysin Induces Death of Prostate Cancer Cells by Inducing ROS and ER Stress.
    J Cell Physiol. 2017 Feb 18. doi: 10.1002/jcp.25861.
    PubMed     Text format     Abstract available


    J Nucl Med

  18. EINSPIELER I, Rauscher I, Duwel C, Kronke M, et al
    Detection efficacy of hybrid 68Ga-PSMA ligand PET/CT in prostate cancer patients with biochemical recurrence after primary radiation therapy defined by Phoenix criteria.
    J Nucl Med. 2017 Feb 16. pii: jnumed.116.184457. doi: 10.2967/jnumed.116.184457.
    PubMed     Text format     Abstract available


    J Urol

  19. TANEJA SS
    Re: Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer.
    J Urol. 2017;197.
    PubMed     Text format    

  20. TANEJA SS
    Re: Quantified Clinical Risk Change as an End Point during Prostate Cancer Active Surveillance.
    J Urol. 2017;197.
    PubMed     Text format    

  21. ATALA A
    Re: Activation of Notch1 Synergizes with Multiple Pathways in Promoting Castration-Resistant Prostate Cancer.
    J Urol. 2017;197.
    PubMed     Text format    

  22. ATALA A
    Re: Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome.
    J Urol. 2017;197.
    PubMed     Text format    

  23. ATALA A
    Re: Integrative Analyses Reveal a Long Noncoding RNA-Mediated Sponge Regulatory Network in Prostate Cancer.
    J Urol. 2017;197.
    PubMed     Text format    

  24. PENSON DF
    Re: Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
    J Urol. 2017;197.
    PubMed     Text format    

  25. PENSON DF
    Re: Association of Androgen Deprivation Therapy with Depression in Localized Prostate Cancer.
    J Urol. 2017;197.
    PubMed     Text format    

  26. PENSON DF
    Re: Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage, and Improve?
    J Urol. 2017;197.
    PubMed     Text format    

  27. MURTOLA TJ, Virkku A, Talala K, Stenman UH, et al
    Outcomes of prostate cancer screening by 5-alpha reductase inhibitor usage.
    J Urol. 2017 Feb 16. pii: S0022-5347(17)30290-2. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available

  28. POMPE RS, Karakiewicz PI, Tian Z, Mandel P, et al
    Oncological and functional outcomes after radical prostatectomy for high or very high-risk prostate cancer - European validation of the current NCCN guideline.
    J Urol. 2017 Feb 16. pii: S0022-5347(17)30291-4. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  29. STONE L
    Prostate cancer: Cholesterol homeostasis - a target for treatment.
    Nat Rev Urol. 2017 Feb 14. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


    PLoS Comput Biol

  30. WALKER AR, Silvestrov P, Muller TA, Podolsky RH, et al
    ALKBH7 Variant Related to Prostate Cancer Exhibits Altered Substrate Binding.
    PLoS Comput Biol. 2017;13:e1005345.
    PubMed     Text format     Abstract available


    PLoS One

  31. BLACKLEDGE MD, Tunariu N, Orton MR, Padhani AR, et al
    Inter- and Intra-Observer Repeatability of Quantitative Whole-Body, Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone Disease.
    PLoS One. 2016;11:e0153840.
    PubMed     Text format     Abstract available


    Urol Int

  32. SAKAI Y, Komai Y, Saito N, Ito M, et al
    Analysis of a Surgical Treatment for Persistent Urorectal Fistulas after Radical Cancer Surgery: A Comparison of Prostate Cancer and Rectal Cancer.
    Urol Int. 2017 Feb 24. doi: 10.1159/000457835.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: